T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding T2 Biosystems, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 62 | 27 | −35 |
| SharesConverted for a 1-for-50 split | 494.0K | 514.4K | +20.4K (+4.1%) |
| Value | $2.79M | $667.5K | −$2.12M (−76.1%) |
New holders (4)
Institutions that held T2 Biosystems, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 4,997 | $7.00K | 0.00% |
| Cowen Prime Advisors LLC | 1,684 | $2.00K | 0.00% |
| Belpointe Asset Management LLC | 162 | $230 | 0.00% |
| JPMorgan Chase & Co | 3 | $0 | 0.00% |
Sold out (39)
Institutions that held T2 Biosystems, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.